Middle East Healthcare Company

TADAWUL:4009.SR

71.8 (SAR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q1
Revenue 712.66689.21719.811671.047624.325637.989617.956512.374508.091513.322498.949498.73456.573418.369470.51492.132373.262436.306406.514386.756353.198350.178310.68338.774346.127395.109417.225396.619391.685423.9404.962379.088410.073421.519418.686352.196372.003391.643369.341323.158359.175
Cost of Revenue 433.59431.391426.952404.721395.693412.493413.944360.169349.322348.3338.841326.459303.928295.213309.762320.226252.775289.447257.928266.796250.441248.551199.125226.909229.219234.69219.125219.68212.654213.063205.078179.878197.981204.98204.648168.967168.126182.653185.711146.491159.688
Gross Profit 279.07257.819292.858266.326228.631225.495204.012152.205158.77165.022160.108172.271152.644123.157160.748171.906120.487146.858148.586119.96102.757101.627111.555111.865116.908160.419198.1176.939179.031210.837199.884199.21212.091216.538214.039183.229203.877208.99183.63176.667199.488
Gross Profit Ratio 0.3920.3740.4070.3970.3660.3530.330.2970.3120.3210.3210.3450.3340.2940.3420.3490.3230.3370.3660.310.2910.290.3590.330.3380.4060.4750.4460.4570.4970.4940.5250.5170.5140.5110.520.5480.5340.4970.5470.555
Reseach & Development Expenses 00000000000000000000000000000000000000000
General & Administrative Expenses 156.13124.576-304.161147.574149.955138.767-287.538118.774127.577125.154-264.403139.836127.78299.198-240.411119.67991.354116.888-201.42982.55492.46780.3872.37988.6281.65872.96-154.2980.2177.25967.79270.23672.20477.02865.49465.79765.6573.86156.2951.64163.31763.646
Selling & Marketing Expenses 17.20817.64322.2678.9019.68810.2229.8746.4959.4234.59225.1419.1355.2226.46710.02310.1085.4075.6055.044.0962.7072.9342.9851.9573.5891.642-111.38445.8762.4014.24141.3134.68258.946.41848.30727.32638.80547.91551.82640.08559.215
SG&A 173.338140.182205.705156.475159.643148.989-277.664125.269137129.746-239.262148.971133.004105.664-230.388129.78796.761122.493-196.38986.65195.17483.31475.36490.57785.24774.602-265.674126.08679.6672.033111.545106.886135.928111.911114.10492.976112.666104.205103.467103.401122.861
Other Expenses -173.347.7314.8464.082.8853.631420.8073.181-1372.311406.883-4.3151.7633.602356.668-1.1731.6892.1913.853.8957.871.298-87.591.8023.37474.602405.079-4.1623.3350-0.956-3.88900-3.137-1.44500000
Operating Expenses 173.34140.182205.705156.475159.643148.989143.143125.269-137129.746167.621144.656133.004105.664126.28128.61496.761122.493102.59986.65195.17483.314-87.5990.57785.24774.602139.405121.92479.6673.43110.589102.997132.995106.977110.96791.531110.9102.29897.21101.113118.889
Operating Income 105.73117.63787.153109.85168.98876.50756.35926.93621.7735.276-6.18923.319.64117.49231.13843.29123.72724.36544.06133.3097.58418.31323.96521.28831.66285.81757.3555.015179.031210.83789.29596.212212.091216.538103.07191.698203.877208.9978.3771.53475.109
Operating Income Ratio 0.1480.1710.1210.1640.1110.120.0910.0530.0430.069-0.0120.0470.0430.0420.0660.0880.0640.0560.1080.0860.0210.0520.0770.0630.0910.2170.1370.1390.4570.4970.2210.2540.5170.5140.2460.260.5480.5340.2120.2210.209
Total Other Income Expenses Net -105.73-58.443-47.767-50.896-22.307-19.911-22.607-15.034-12.282-9.199-9.087-11.05-10.636-6.91-3.952-7.82-9.081-5.321-6.39-2.1642.503-3.8586.815-1.0021.6310.49111.02-1.447-0.816-0.338-3.73-4.717-1.4763.052-0.841-1.01-1.2642.4466.3123.0214.971
Income Before Tax 67.41959.19439.38658.95446.68256.59533.75211.9039.48726.077-16.91916.5659.00410.58230.51535.47114.64519.04439.59731.14510.08614.45530.7820.28633.29286.30869.71553.56858.149106.69885.56491.495210.615104.2102.23190.689202.613105.33584.68274.55480.08
Income Before Tax Ratio 0.0950.0860.0550.0880.0750.0890.0550.0230.0190.051-0.0340.0330.020.0250.0650.0720.0390.0440.0970.0810.0290.0410.0990.060.0960.2180.1670.1350.1480.2520.2110.2410.5140.2470.2440.2570.5450.2690.2290.2310.223
Income Tax Expense 7.2647.2243.9334.7254.74.625-0.2093.4160.3946.01632.50.51.521.50.51.51.6631.50.51.5131.5251.5251.025-0.821-1.5761.015-57.098-98.538-2.055-0.53133.592-105.192-0.085-0.065110.822-105.390.1460.241-0.079
Net Income 61.17151.94336.50253.30340.25450.11733.1618.48710.42820.488-18.39314.3539.13912.10228.53234.91416.35321.18537.46833.23112.27614.59330.68720.16134.27387.12977.83564.88461.949109.96887.61999.64473.075104.025102.31590.75491.791105.3984.64374.36680.159
Net Income Ratio 0.0860.0750.0510.0790.0640.0790.0540.0170.0210.04-0.0370.0290.020.0290.0610.0710.0440.0490.0920.0860.0350.0420.0990.060.0990.2210.1870.1640.1580.2590.2160.2630.1780.2470.2440.2580.2470.2690.2290.230.223
EPS 0.660.560.40.580.440.540.360.0920.110.22-0.170.160.10.130.310.380.180.230.410.360.130.160.330.220.370.950.850.70.671.20.951.080.81.131.120.9911.150.920.8080.871
EPS Diluted 0.660.560.40.580.440.540.360.0920.110.22-0.170.160.10.130.310.380.180.230.410.360.130.160.330.220.370.950.850.70.671.20.951.080.81.131.120.9911.150.920.8080.871
EBITDA 182.853168.969136.757159.331120.676126.14292.90930.11727.8270.57428.12162.63455.09856.31169.49477.22858.52152.76468.28962.19840.75442.47635.3245.89135.03688.32572.4155.015179.031210.837104.39998.545212.091216.538116.67493.743203.877208.9990.21383.11185.357
EBITDA Ratio 0.2570.2450.190.2370.1930.1980.150.0590.0550.1370.0560.1260.1210.1350.1480.1570.1570.1210.1680.1610.1150.1210.1140.1350.1010.2240.1740.1390.4570.4970.2580.260.5170.5140.2790.2660.5480.5340.2440.2570.238